This is well documented in literature where it is asserted that the cardiac PET imaging using [18F]-Florbetaben well characterizes the presence of type AL amyloidosis, while it is not able to determine the ATTR and to distinguish it from other pathologies or from the non-presence of cardiac pathology [30]. The gene discussed is TTR; the disease is AL amyloidosis.